Back

Choose your region

Corporate

Europe:

Flag Albania Albania Flag Bosnia-Herzegovina Bosnia-Herzegovina Flag Bulgaria Bulgaria Flag Croatia Croatia Flag Cyprus Cyprus Flag Czech Republic Czech Republic Flag Denmark Denmark Flag Estonia Estonia Flag Germany Germany Flag Hungary Hungary Flag Italy Italy Flag Kosovo Kosovo Flag Latvia Latvia Flag Lithuania Lithuania Flag Luxembourg Luxembourg Flag Macedonia Macedonia Flag Montenegro Montenegro Flag Poland Poland (Lab) Flag Portugal Portugal (Lab) Flag Romania Romania (Lab) Flag Serbia Serbia Flag Slovakia Slovakia Flag Slovenia Slovenia Flag Spain Spain (Lab) Flag Switzerland Switzerland (Lab) Flag Sweden Sweden Flag Turkey Turkey (Lab) Flag United Kingdom United Kingdom

Asia:

Flag UAE UAE Flag Hong Kong Hong Kong Flag Kuwait Kuwait Flag Lebanon Lebanon

Africa:

Flag South Africa South Africa

Summary
patients treated

Has anyone ever benefited from stem cell?

For the first time, umbilical cord blood cells were successfully used in 1988 in France. Several years later, in 2007, this method was also introduced by FamiCord Group in Poland. So far, umbilical cord blood stem cells have been transplanted over 40,000 times worldwide, saving peoples’ lives and health.

FamiCord Group enables their clients innovative treatment with stem cells. Check the full list of patients, suffered from diverse disorders, who benefited from it.

List of patients

List of patients
No. Source Source type Diagnosis Medical sector Year of application Therapy Country Age of the recipient
3701 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 35
3702 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 70
3703 Apheresis Allogeneic Multiple Myeloma Hematology 2019 Standard Therapy Germany 57
3704 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 41
3705 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 60
3706 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 68
3707 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 65
3708 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 63
3709 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 65
3710 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 66
3711 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 57
3712 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 65
3713 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 67
3714 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 64
3715 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 70
3716 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 64
3717 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 66
3718 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 68
3719 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 58
3720 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 59
3721 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 72
3722 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 65
3723 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 62
3724 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 55
3725 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 62
3726 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 14
3727 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 61
3728 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 61
3729 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 75
3730 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 45
3731 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 70
3732 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 72
3733 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 69
3734 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 45
3735 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 40
3736 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 65
3737 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 72
3738 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 50
3739 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 59
3740 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 66
3741 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 61
3742 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 42
3743 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 68
3744 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 65
3745 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 56
3746 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 63
3747 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 62
3748 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 64
3749 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 42
3750 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 68
3751 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 61
3752 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 68
3753 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 62
3754 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 66
3755 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 66
3756 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 67
3757 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 4
3758 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 56
3759 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 66
3760 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 62
3761 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 61
3762 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 61
3763 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 63
3764 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 44
3765 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 45
3766 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 33
3767 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 66
3768 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 65
3769 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 49
3770 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 69
3771 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 71
3772 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 25
3773 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 42
3774 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 46
3775 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 65
3776 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Germany 49
3777 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Germany 66
3778 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Germany 64
3779 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Germany 67
3780 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Germany 66
3781 Apheresis Allogeneic Myelodysplastic Syndrome – Raeb Hematology 2019 Standard Therapy Poland 21
3782 Apheresis Allogeneic Myelodysplastic Syndrome – Raeb Hematology 2019 Standard Therapy Poland 16
3783 Apheresis Allogeneic Myelodysplastic Syndrome; Myeloproliferative Neoplasms Overlap Hematology 2019 Standard Therapy Germany 64
3784 Apheresis Allogeneic Myelofibrosis Hematology 2019 Standard Therapy Poland 46
3785 Apheresis Allogeneic Myelofibrosis Hematology 2019 Standard Therapy Poland 62
3786 Apheresis Allogeneic Myelofibrosis Hematology 2019 Standard Therapy Poland 47
3787 Apheresis Allogeneic Myelofibrosis Hematology 2019 Standard Therapy Poland 33
3788 Apheresis Allogeneic Myelofibrosis Hematology 2019 Standard Therapy Poland 45
3789 Apheresis Allogeneic Myelofibrosis Hematology 2019 Standard Therapy Poland 43
3790 Apheresis Allogeneic Myelofibrosis With Myeloid Metaplasia Hematology 2019 Standard Therapy Poland 66
3791 Apheresis Allogeneic Myelofibrosis With Myeloid Metaplasia Hematology 2019 Standard Therapy Poland 69
3792 Apheresis Allogeneic Myelofibrosis With Myeloid Metaplasia Hematology 2019 Standard Therapy Poland 63
3793 Apheresis Allogeneic Myelofibrosis With Myeloid Metaplasia Hematology 2019 Standard Therapy Poland 61
3794 Apheresis Allogeneic Myelofibrosis With Myeloid Metaplasia Hematology 2019 Standard Therapy Poland 61
3795 Apheresis Allogeneic Myeloma Multiplex Hematology 2019 Standard Therapy Poland 45
3796 Apheresis Allogeneic Myeloma Multiplex Hematology 2019 Standard Therapy Poland 62
3797 Apheresis Autologous Myeloma; Amyloidosis Hematology 2019 Standard Therapy Germany 47
3798 Apheresis Autologous Natural Killer / T-Cell-Non-Hodgkin-Lymphoma Hematology 2019 Standard Therapy Germany 32
3799 Apheresis Allogeneic No Data Hematology 2019 Standard Therapy Poland 43
3800 Apheresis Allogeneic No Data Hematology 2019 Standard Therapy Poland 20